Clinical Trial Update: Study of YOLT-202 in the Treatment of Alpha-1 Antitrypsin Deficiency (AATD) [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial to study YOLT-202 for Alpha-1 antitrypsin deficiency is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency

Drugs mentioned

• YOLT-202

Snippet

Sponsor: RenJi Hospital | Conditions: Alpha-1 Antitrypsin Deficiency (AATD) | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING